Axsome Therapeutics, Inc. (19X)
XSTU
Real-time Data
06:00 AM
Day's Range
176.1052 wk Range
95.48Overview - 19X - Axsome Therapeutics, Inc.
Key Statistics
Valuation
Enterprise Value
7.87B
P/E (Trailing)
‪-47.55‬
PEG Ratio
‪-14.50‬
Price / Sales (TTM)
‪12.50‬
Price / Book
‪164.13‬
EV / EBITDA
‪-49.18‬
Profitability
Gross Margin
‪92.29%‬
Profit Margin
‪92.56%‬
Operating Margin
‪-27.74%‬
Return on Assets
‪-26.55%‬
Return on Equity
‪-207.45%‬
Ownership
Shares Outstanding
51.42M
Price stats
50-Day Avg
‪139.47‬
200-Day Avg
‪110.06‬
Market Cap - 19X - Axsome Therapeutics, Inc.
Peers - 19X - Axsome Therapeutics, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on XSTU.
- 19XXSTUAxsome Therapeutics, Inc.7.98BMarket Cap+43.86%52-week change-48.38P/E (Trailing)‪92.56%‬Profit Margin
- 6IBXSTUInnovent Biologics Inc.14.71BMarket Cap+5.19%52-week change—P/E (Trailing)‪86.53%‬Profit Margin
- 4KBXSTUKrystal Biotech Inc.8.74BMarket Cap+57.88%52-week change44.81P/E (Trailing)‪54.81%‬Profit Margin
- 2X10XSTUAbivax SA ADR8.72BMarket Cap+35.02%52-week change-20.39P/E (Trailing)‪0.00%‬Profit Margin
- 30JXSTUIdeaya Biosciences Inc.3.25BMarket Cap+33.59%52-week change-26.12P/E (Trailing)‪-74.75%‬Profit Margin
- AN6XSTUAnaptysBio Inc.1.48BMarket Cap+65.30%52-week change-107.13P/E (Trailing)—Profit Margin
- BSFAXSTUAni Pharmaceuticals Inc.1.45BMarket Cap-21.26%52-week change16.28P/E (Trailing)‪11.07%‬Profit Margin
Profile Summary - 19X - Axsome Therapeutics, Inc.
About
Axsome Therapeutics is a commercial-stage biopharmaceutical company specializing in the development and commercialization of small-molecule medicines and novel therapies targeting central nervous system disorders. The company focuses on conditions with limited treatment options, including depression, Alzheimer's…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
